For example, a CD4:CD8 ratio higher than 10 is observed in about 80% of patients with SS, whereas loss of CD7 (CD4+CD7− ≥30%) or CD26 (CD4+CD26− ≥40%) is found in about half of the SS patients (50–52). Here, CD7 is linked to synovial sarcoma.